ISSVA Classification of Vascular Anomalies ©2018 International Society for the Study of Vascular Anomalies Available at: issva.org/classification. Accessed 17.11.2024
Akers A, Al-Shahi Salman R, Awad IA, Dahlem K, Flemming K, Hart B, Kim H, Jusue-Torres I, Kondziolka D, Lee C, Morrison L, Rigamonti D, Rebeiz T, Tournier-Lasserve E, Waggoner D, Whitehead K. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the angioma alliance scientific advisory board clinical experts panel. Neurosurgery. 2017;80(5):665–80.
Article PubMed PubMed Central Google Scholar
Idiculla PS, Gurala D, Philipose J, Rajdev K, Patibandla P. Cerebral cavernous malformations, developmental venous anomaly, and its coexistence: a review. Eur Neurol. 2020;83(4):360–8.
San MillánRuíz D, Delavelle J, Yilmaz H, Gailloud P, Piovan E, Bertramello A, et al. Parenchymal abnormalities associated with de- velopmental venous anomalies. Neuroradiology. 2007;49(12):987–95.
Das KK, Rangari K, Singh S, Bhaisora KS, Jaiswal AK, Behari S. Coexistent cerebral cavernous malformation and developmental venous anomaly: does an aggressive natural history always call for surgical intervention? Asian J Neurosurg. 2019;14(1):318–21. https://doi.org/10.4103/ajns.AJNS_196_18.
Article PubMed PubMed Central Google Scholar
Abdulrauf SI, Kaynar MY, Awad IA. A com- parison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery. 1999;44(1):41–7.
Article CAS PubMed Google Scholar
Smith ER. Cavernous malformations of the central nervous system. N Engl J Med. 2024;390(11):1022–8.
Article CAS PubMed Google Scholar
Tasiou A, et al. Cavernous malformations of the central nervous system: An international consensus statement. Brain and Spine. 2023;3:102707 (ISSN 2772-5294).
Article PubMed PubMed Central Google Scholar
Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg. 2014;120(5):1188–92.
Sandmann ACA, Kempeneers MA, van den Berg R, Verbaan D, Vandertop WP, Coutinho JM. Clinical course of patients with conservatively managed cerebral cavernous malformations. Eur Stroke J. 2024;9(3):667–75.
Article PubMed PubMed Central Google Scholar
Zabramski JM, Wascher TM, Spetzler RF, Johnson B, Golfinos J, Drayer BP, Brown B, Rigamonti D, Brown G. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80:422–32.
Article CAS PubMed Google Scholar
Dalyai RT, Ghobrial G, Awad I, et al. Management of incidental cavernous malformations: a review. Neurosurg Focus. 2011;31(6):E5.
Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskimäki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad IA. Atorvastatin treatment of cavernous angiomas with symptomatic hemorrhage exploratory proof of concept (AT CASH EPOC) Trial. Neurosurgery. 2019;85(6):843–53. https://doi.org/10.1093/neuros/nyy539.
Retta SF, Glading AJ. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: two sides of the same coin. Int J Biochem Cell Biol. 2016;81(Pt B):254–70. https://doi.org/10.1016/j.biocel.2016.09.011.
Article CAS PubMed PubMed Central Google Scholar
Wurm G, Schnizer M, Fellner FA. Cerebral cavernous malformations associated with venous anomalies: surgical considerations. Neurosurgery. 2005;57(1 Suppl):42–58.
Amin-Hanjani S, Ogilvy CS, Ojemann RG, Crowell RM. Risks of surgical management for cavernous malformations of the nervous system. Neurosurgery. 1998;42(6):1220–7. https://doi.org/10.1097/00006123-199806000-00007.
Article CAS PubMed Google Scholar
Bubenikova A, Skalicky P, Benes V Jr, Benes V Sr, Bradac O. Overview of cerebral cavernous malformations: comparison of treatment approaches. J Neurol Neurosurg Psychiatry. 2022;93(5):475–80. https://doi.org/10.1136/jnnp-2021-328658.
Zanello M. Resection of cavernous angioma located in eloquent areas using functional cortical and subcortical mapping under awake conditions. Outcomes in a 50-case multicentre series. Neurochirurgie. 2017;63(3):219–26.
Article CAS PubMed Google Scholar
Tos SM, et al. Radiosurgery for intracranial cavernous malformations: international stereotactic radiosurgery society, systematic review, meta-analysis, and practice guidelines. World Neurosurg. 2024;192:e366–401 (ISSN 1878-8750).
Kim BS, Kim KH, Lee MH, Lee JI. Stereotactic radiosurgery for brainstem cavernous malformations: an updated systematic review and meta-analysis. World Neurosurg. 2019;130:e648–59. https://doi.org/10.1016/j.wneu.2019.06.183.
Khallaf M, Abdelrahman M. Supratentorial cavernoma and epilepsy: experience with 23 cases and literature review. Surg Neurol Int. 2019;10:117. https://doi.org/10.25259/SNI-178-2019.
Article PubMed PubMed Central Google Scholar
Rosenow F, Alonso-Vanegas MA, Baumgartner C, et al. Cavernoma-related epilepsy: review and recommendations for management–report of the surgical task force of the ILAE commission on therapeutic strategies. Epilepsia. 2013;54(12):2025–35.
Baumann CR, Acciarri N, Bertalanffy H, Devinsky O, Elger CE, Lo Russo G, Cossu M, Sure U, Singh A, Stefan H, Hammen T, Georgiadis D, Baumgartner RW, Andermann F, Siegel AM. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia. 2007;48(3):559–63. https://doi.org/10.1111/j.1528-1167.2006.00941.x.
Kapadia M, Walwema M, Smith TR, Bellinski I, Batjer H, Getch C, Rosenow JM, Bendok BR, Schuele SU. Seizure outcome in patients with cavernous malformation after early surgery. Epilepsy Behav. 2021;115:107662. https://doi.org/10.1016/j.yebeh.2020.107662.
Dulamea AO, Lupescu IC. Cerebral cavernous malformations - an overview on genetics, clinical aspects and therapeutic strategies. J Neurol Sci. 2024;461:123044. https://doi.org/10.1016/j.jns.2024.123044.
Article CAS PubMed Google Scholar
Oldenburg J. Propranolol reduces the development of lesions and rescues barrier function in cerebral cavernous malformations a preclinical study. Stroke. 2021;52(4):1418–27.
Article CAS PubMed Google Scholar
Lanfranconi S, Scola E, Meessen JMTA, Pallini R, Bertani GA, Al-Shahi Salman R, Dejana E, Latini R. Treat_CCM Investigators. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial. Lancet Neurol. 2023;22(1):35–44. https://doi.org/10.1016/S1474-4422(22)00409-4.
Article CAS PubMed Google Scholar
Zabramski JM, Kalani MYS, Filippidis AS, Spetzler RF. Propranolol treatment of cavernous malformations with symptomatic hemorrhage. World Neurosurg. 2016;88:631–9. https://doi.org/10.1016/j.wneu.2015.11.003.
Reinhard M, Schuchardt F, Meckel S, Heinz J, Felbor U, Sure U, Geisen U. Propranolol stops progressive multiple cerebral cavernoma in an adult patient. J Neurol Sci. 2016;15(367):15–7. https://doi.org/10.1016/j.jns.2016.04.053.
Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, et al. The cerebral cav- ernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med. 2009;15:177–84.
Article CAS PubMed PubMed Central Google Scholar
McDonald D, et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012;43(2):571–4.
留言 (0)